Silver-Based Coating Reduces Microbial Contamination of Lab Equipment
By LabMedica International staff writers Posted on 16 Apr 2009 |
Technological advances in the manufacture of materials and coatings allow inorganic silver ions to be incorporated into laboratory instruments at the time of manufacture. Silver is an active antimicrobial against a wide range of bacteria and fungi.
Silver ions disrupt the microbial cell membrane function and cause denaturing of vital enzymes within the cell, leading to rapid cell death. It is thought that silver prevents bonds between the two strands of the double-stranded helix from separating, thereby causing the inhibition of transcription and DNA replication. The silver ions are slowly released from an inorganic matrix via an ion exchange mechanism, maintaining an effective concentration on or near the surface of the material. Active throughout the useful life of each instrument, the coating kills a wide range of bacteria and fungi, including methicillin resistant Staphylococcus aureus (MRSA), Escherichia coli, Legionella, Staphylococcus aureus, and Aspergillus niger.
A two-month environmental study carried out in a lab at the University of Birmingham (Birmingham, UK) demonstrated that silver-based BioCote antimicrobial protection, an integral feature of all Stuart benchtop laboratory equipment, reduces bacterial contamination of instrument surfaces by almost 100%. The Stuart range of benchtop equipment comprises over 100 products including block heaters, blood tube rotators, shakers, stirrers, and water baths
Bacterial surface contamination of six BioCote-treated Stuart instruments, such as hotplate stirrers and a mixer, was compared with untreated instruments in the same laboratory. All items included in the study had been in routine use for around 18 months. Swabs from touchpads, switches, casings etc. were collected fortnightly for two months and Total Viable Counts (TVC) were obtained after inoculation and incubation of plate count agar. There was a mean reduction in excess of 96 % in the TVC of bacteria contaminating the BioCote-treated equipment, compared with untreated control items in the same environment.
Rob Skehens, marketing director, Bibby Scientific (Stone, UK) commented, 'This important study suggests that BioCote antimicrobial protection has a vital role to play, complementing established GLP [good laboratory practice] and GMP [good microbiology practice] protocols, in ensuring that laboratory environments comply with the highest health and safety standards. While surface disinfection in the laboratory will always be essential, permanent antimicrobial surfaces of instruments represent a powerful weapon against the hazards of lab-acquired infection and contamination of precious experimental or test samples. This is particularly true for surfaces subjected to physical contact with reagents, or repeated hand contact by multiple users.
Related Links:
University of Birmingham
Silver ions disrupt the microbial cell membrane function and cause denaturing of vital enzymes within the cell, leading to rapid cell death. It is thought that silver prevents bonds between the two strands of the double-stranded helix from separating, thereby causing the inhibition of transcription and DNA replication. The silver ions are slowly released from an inorganic matrix via an ion exchange mechanism, maintaining an effective concentration on or near the surface of the material. Active throughout the useful life of each instrument, the coating kills a wide range of bacteria and fungi, including methicillin resistant Staphylococcus aureus (MRSA), Escherichia coli, Legionella, Staphylococcus aureus, and Aspergillus niger.
A two-month environmental study carried out in a lab at the University of Birmingham (Birmingham, UK) demonstrated that silver-based BioCote antimicrobial protection, an integral feature of all Stuart benchtop laboratory equipment, reduces bacterial contamination of instrument surfaces by almost 100%. The Stuart range of benchtop equipment comprises over 100 products including block heaters, blood tube rotators, shakers, stirrers, and water baths
Bacterial surface contamination of six BioCote-treated Stuart instruments, such as hotplate stirrers and a mixer, was compared with untreated instruments in the same laboratory. All items included in the study had been in routine use for around 18 months. Swabs from touchpads, switches, casings etc. were collected fortnightly for two months and Total Viable Counts (TVC) were obtained after inoculation and incubation of plate count agar. There was a mean reduction in excess of 96 % in the TVC of bacteria contaminating the BioCote-treated equipment, compared with untreated control items in the same environment.
Rob Skehens, marketing director, Bibby Scientific (Stone, UK) commented, 'This important study suggests that BioCote antimicrobial protection has a vital role to play, complementing established GLP [good laboratory practice] and GMP [good microbiology practice] protocols, in ensuring that laboratory environments comply with the highest health and safety standards. While surface disinfection in the laboratory will always be essential, permanent antimicrobial surfaces of instruments represent a powerful weapon against the hazards of lab-acquired infection and contamination of precious experimental or test samples. This is particularly true for surfaces subjected to physical contact with reagents, or repeated hand contact by multiple users.
Related Links:
University of Birmingham
Latest Technology News
- Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
- Paper-Based Biosensor System to Detect Glucose Using Sweat Could Revolutionize Diabetes Management
Channels
Clinical Chemistry
view channel
Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Genetic-Based Tool Predicts Survival Outcomes of Pancreatic Cancer Patients
A tumor marker is a substance found in the body that may signal the presence of cancer. These substances, which can include proteins, genes, molecules, or other biological compounds, are either produced... Read more
Urine Test Diagnoses Early-Stage Prostate Cancer
Prostate cancer is one of the leading causes of death among men worldwide. A major challenge in diagnosing the disease is the absence of reliable biomarkers that can detect early-stage tumors.... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read more
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
AI-Based Model Predicts Kidney Cancer Therapy Response
Each year, nearly 435,000 individuals are diagnosed with clear cell renal cell carcinoma (ccRCC), making it the most prevalent subtype of kidney cancer. When the disease spreads, anti-angiogenic therapies... Read more
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more